Edition:
United Kingdom

CASI Pharmaceuticals Inc (CASI.OQ)

CASI.OQ on NASDAQ Stock Exchange Capital Market

3.64USD
18 Jan 2019
Change (% chg)

$-0.16 (-4.21%)
Prev Close
$3.80
Open
$3.81
Day's High
$3.83
Day's Low
$3.62
Volume
85,482
Avg. Vol
112,682
52-wk High
$8.88
52-wk Low
$2.74

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.00 -0.101
Jun '18 0.00 -0.068
Mar '18 0.00 -0.050
FY 2017 Dec '17 0.00 -0.077
Sep '17 0.00 -0.027
Jun '17 0.00 -0.040
Mar '17 0.00 -0.028
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-19 3 7.97 10.85 3.42 12.11
Earnings (per share)
Quarter Ending Mar-19 1 -0.08 -0.08 -0.08 --
Quarter Ending Jun-19 1 -0.09 -0.09 -0.09 --
Year Ending Dec-19 3 -0.22 -0.15 -0.35 -0.02
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.71 33.71
P/E High - Last 5 Yrs. -- 148.01 49.93
P/E Low - Last 5 Yrs. -- 47.79 24.27
Beta 0.94 1.08 0.90
Price to Sales (TTM) -- 49.51 6.28
Price to Book (MRQ) 6.65 10.16 5.27
Price to Tangible Book (MRQ) 6.65 13.82 6.79
Price to Cash Flow (TTM) -- 52.80 24.84
% Owned Institutions 14.25 3.75 1.69

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.40
Dividend Yield - 5 Year Avg -- 0.09 1.42
Dividend 5 Year Growth Rate -- 0.79 4.83
Payout Ratio(TTM) -- 7.04 41.08

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 130.04 9.72
Sales (TTM) vs TTM 1 Yr. Ago -- 47.85 5.87
Sales - 5 Yr. Growth Rate -- 22.76 11.20
EPS (MRQ) vs Qtr. 1 Yr. Ago 47.85 75.87 47.26
EPS (TTM) vs TTM 1 Yr. Ago 40.88 -- --
EPS - 5 Yr. Growth Rate -- 12.03 10.82
Capital Spending - 5 Yr. Growth Rate 106.12 9.25 15.18

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.18 2.26
Current Ratio (MRQ) 7.90 3.43 3.08
LT Debt to Equity (MRQ) 0.00 18.73 11.38
Total Debt to Equity (MRQ) 8.78 31.43 16.13
Interest Coverage (TTM) -691.56 -43.27 29.51

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.29 53.78
Gross Margin - 5 Yr. Avg. -- 60.55 52.17
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -7,125.71 -110.23 12.87
Operating Margin (TTM) -- -184.42 6.20
Operating Margin - 5 Yr. Avg. -7,155.52 -126.68 8.31
Pre-Tax Margin (TTM) -- -175.20 7.17
Pre-Tax Margin - 5 Yr. Avg. -8,524.58 -132.83 8.61
Net Profit Margin (TTM) -- -181.93 3.30
Net Profit Margin - 5 Yr. Avg. -8,524.58 -137.23 4.88
Effective Tax Rate (TTM) -- 21.48 22.88
Effective Tax Rate - 5 Yr. Avg. -- 15.57 23.39

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 7,650,725 844,239,694
Net Income/Employee (TTM) -- 652,578 100,064,161
Receivable Turnover (TTM) -- 6.25 5.72
Inventory Turnover (TTM) -- 1.89 3.48
Asset Turnover (TTM) 0.00 0.32 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -39.33 6.45 11.08
Return on Assets - 5 Yr. Avg. -110.60 5.52 12.21
Return on Investment (TTM) -45.17 8.99 14.48
Return on Investment - 5 Yr. Avg. -119.58 6.85 15.88
Return on Equity (TTM) -62.67 10.13 15.99
Return on Equity - 5 Yr. Avg. -238.20 8.39 17.00
  1 Year 3 Year 5 Year
Sales % -100.00 -- --
EPS (TTM) % 23.82 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for CASI Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 79.05 72.87 97 99
13 Week 67.86 59.68 93 95
26 Week 67.86 55.10 88 98
52 Week 54.10 30.61 79 72
YTD 63.48 43.57 78 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 20.73%
# of Holders: 92
Total Shares Held: 19,398,644
3 Mo. Net Change: 1,368
# New Positions: 1
# Closed Positions: 2
# Increased Positions: 5
# Reduced Positions: 5
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.